Copyright Reports & Markets. All rights reserved.

Global Coagulation Factor II Antibody Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Coagulation Factor II Antibody Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Monoclonal Antibody
    • 1.3.3 Polyclonal Antibody
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Coagulation Factor II Antibody Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Flow Cytometry
    • 1.4.3 ELISA
    • 1.4.4 Western Blot
    • 1.4.5 Immunoprecipitation
    • 1.4.6 Immunofluorescence
    • 1.4.7 Other
  • 1.5 Global Coagulation Factor II Antibody Market Size & Forecast
    • 1.5.1 Global Coagulation Factor II Antibody Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Coagulation Factor II Antibody Sales Quantity (2021-2032)
    • 1.5.3 Global Coagulation Factor II Antibody Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 MyBiosource, Inc.
    • 2.1.1 MyBiosource, Inc. Details
    • 2.1.2 MyBiosource, Inc. Major Business
    • 2.1.3 MyBiosource, Inc. Coagulation Factor II Antibody Product and Services
    • 2.1.4 MyBiosource, Inc. Coagulation Factor II Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 MyBiosource, Inc. Recent Developments/Updates
  • 2.2 LifeSpan BioSciences, Inc
    • 2.2.1 LifeSpan BioSciences, Inc Details
    • 2.2.2 LifeSpan BioSciences, Inc Major Business
    • 2.2.3 LifeSpan BioSciences, Inc Coagulation Factor II Antibody Product and Services
    • 2.2.4 LifeSpan BioSciences, Inc Coagulation Factor II Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 LifeSpan BioSciences, Inc Recent Developments/Updates
  • 2.3 Assay Genie
    • 2.3.1 Assay Genie Details
    • 2.3.2 Assay Genie Major Business
    • 2.3.3 Assay Genie Coagulation Factor II Antibody Product and Services
    • 2.3.4 Assay Genie Coagulation Factor II Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Assay Genie Recent Developments/Updates
  • 2.4 Arigo Biolaboratories Corp.
    • 2.4.1 Arigo Biolaboratories Corp. Details
    • 2.4.2 Arigo Biolaboratories Corp. Major Business
    • 2.4.3 Arigo Biolaboratories Corp. Coagulation Factor II Antibody Product and Services
    • 2.4.4 Arigo Biolaboratories Corp. Coagulation Factor II Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Arigo Biolaboratories Corp. Recent Developments/Updates
  • 2.5 RayBiotech, Inc.
    • 2.5.1 RayBiotech, Inc. Details
    • 2.5.2 RayBiotech, Inc. Major Business
    • 2.5.3 RayBiotech, Inc. Coagulation Factor II Antibody Product and Services
    • 2.5.4 RayBiotech, Inc. Coagulation Factor II Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 RayBiotech, Inc. Recent Developments/Updates
  • 2.6 Biorbyt
    • 2.6.1 Biorbyt Details
    • 2.6.2 Biorbyt Major Business
    • 2.6.3 Biorbyt Coagulation Factor II Antibody Product and Services
    • 2.6.4 Biorbyt Coagulation Factor II Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Biorbyt Recent Developments/Updates
  • 2.7 Creative Biolabs
    • 2.7.1 Creative Biolabs Details
    • 2.7.2 Creative Biolabs Major Business
    • 2.7.3 Creative Biolabs Coagulation Factor II Antibody Product and Services
    • 2.7.4 Creative Biolabs Coagulation Factor II Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Creative Biolabs Recent Developments/Updates
  • 2.8 GeneTex
    • 2.8.1 GeneTex Details
    • 2.8.2 GeneTex Major Business
    • 2.8.3 GeneTex Coagulation Factor II Antibody Product and Services
    • 2.8.4 GeneTex Coagulation Factor II Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 GeneTex Recent Developments/Updates
  • 2.9 OriGene Technologies, Inc.
    • 2.9.1 OriGene Technologies, Inc. Details
    • 2.9.2 OriGene Technologies, Inc. Major Business
    • 2.9.3 OriGene Technologies, Inc. Coagulation Factor II Antibody Product and Services
    • 2.9.4 OriGene Technologies, Inc. Coagulation Factor II Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 OriGene Technologies, Inc. Recent Developments/Updates
  • 2.10 ​​Abcam
    • 2.10.1 ​​Abcam Details
    • 2.10.2 ​​Abcam Major Business
    • 2.10.3 ​​Abcam Coagulation Factor II Antibody Product and Services
    • 2.10.4 ​​Abcam Coagulation Factor II Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 ​​Abcam Recent Developments/Updates
  • 2.11 Cell Signaling Technology, Inc.
    • 2.11.1 Cell Signaling Technology, Inc. Details
    • 2.11.2 Cell Signaling Technology, Inc. Major Business
    • 2.11.3 Cell Signaling Technology, Inc. Coagulation Factor II Antibody Product and Services
    • 2.11.4 Cell Signaling Technology, Inc. Coagulation Factor II Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Cell Signaling Technology, Inc. Recent Developments/Updates
  • 2.12 Abbexa
    • 2.12.1 Abbexa Details
    • 2.12.2 Abbexa Major Business
    • 2.12.3 Abbexa Coagulation Factor II Antibody Product and Services
    • 2.12.4 Abbexa Coagulation Factor II Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Abbexa Recent Developments/Updates
  • 2.13 Bio-Techne
    • 2.13.1 Bio-Techne Details
    • 2.13.2 Bio-Techne Major Business
    • 2.13.3 Bio-Techne Coagulation Factor II Antibody Product and Services
    • 2.13.4 Bio-Techne Coagulation Factor II Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Bio-Techne Recent Developments/Updates

3 Competitive Environment: Coagulation Factor II Antibody by Manufacturer

  • 3.1 Global Coagulation Factor II Antibody Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Coagulation Factor II Antibody Revenue by Manufacturer (2021-2026)
  • 3.3 Global Coagulation Factor II Antibody Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Coagulation Factor II Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Coagulation Factor II Antibody Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Coagulation Factor II Antibody Manufacturer Market Share in 2025
  • 3.5 Coagulation Factor II Antibody Market: Overall Company Footprint Analysis
    • 3.5.1 Coagulation Factor II Antibody Market: Region Footprint
    • 3.5.2 Coagulation Factor II Antibody Market: Company Product Type Footprint
    • 3.5.3 Coagulation Factor II Antibody Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Coagulation Factor II Antibody Market Size by Region
    • 4.1.1 Global Coagulation Factor II Antibody Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Coagulation Factor II Antibody Consumption Value by Region (2021-2032)
    • 4.1.3 Global Coagulation Factor II Antibody Average Price by Region (2021-2032)
  • 4.2 North America Coagulation Factor II Antibody Consumption Value (2021-2032)
  • 4.3 Europe Coagulation Factor II Antibody Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Coagulation Factor II Antibody Consumption Value (2021-2032)
  • 4.5 South America Coagulation Factor II Antibody Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Coagulation Factor II Antibody Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Coagulation Factor II Antibody Sales Quantity by Type (2021-2032)
  • 5.2 Global Coagulation Factor II Antibody Consumption Value by Type (2021-2032)
  • 5.3 Global Coagulation Factor II Antibody Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Coagulation Factor II Antibody Sales Quantity by Application (2021-2032)
  • 6.2 Global Coagulation Factor II Antibody Consumption Value by Application (2021-2032)
  • 6.3 Global Coagulation Factor II Antibody Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Coagulation Factor II Antibody Sales Quantity by Type (2021-2032)
  • 7.2 North America Coagulation Factor II Antibody Sales Quantity by Application (2021-2032)
  • 7.3 North America Coagulation Factor II Antibody Market Size by Country
    • 7.3.1 North America Coagulation Factor II Antibody Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Coagulation Factor II Antibody Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Coagulation Factor II Antibody Sales Quantity by Type (2021-2032)
  • 8.2 Europe Coagulation Factor II Antibody Sales Quantity by Application (2021-2032)
  • 8.3 Europe Coagulation Factor II Antibody Market Size by Country
    • 8.3.1 Europe Coagulation Factor II Antibody Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Coagulation Factor II Antibody Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Coagulation Factor II Antibody Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Coagulation Factor II Antibody Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Coagulation Factor II Antibody Market Size by Region
    • 9.3.1 Asia-Pacific Coagulation Factor II Antibody Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Coagulation Factor II Antibody Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Coagulation Factor II Antibody Sales Quantity by Type (2021-2032)
  • 10.2 South America Coagulation Factor II Antibody Sales Quantity by Application (2021-2032)
  • 10.3 South America Coagulation Factor II Antibody Market Size by Country
    • 10.3.1 South America Coagulation Factor II Antibody Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Coagulation Factor II Antibody Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Coagulation Factor II Antibody Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Coagulation Factor II Antibody Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Coagulation Factor II Antibody Market Size by Country
    • 11.3.1 Middle East & Africa Coagulation Factor II Antibody Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Coagulation Factor II Antibody Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Coagulation Factor II Antibody Market Drivers
  • 12.2 Coagulation Factor II Antibody Market Restraints
  • 12.3 Coagulation Factor II Antibody Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Coagulation Factor II Antibody and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Coagulation Factor II Antibody
  • 13.3 Coagulation Factor II Antibody Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Coagulation Factor II Antibody Typical Distributors
  • 14.3 Coagulation Factor II Antibody Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Coagulation Factor II Antibody market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Coagulation Factor II Antibody is an unconjugated antibody to Coagulation Factor II.
    According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
    This report is a detailed and comprehensive analysis for global Coagulation Factor II Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Coagulation Factor II Antibody market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Coagulation Factor II Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Coagulation Factor II Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Coagulation Factor II Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Coagulation Factor II Antibody
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Coagulation Factor II Antibody market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MyBiosource, Inc., LifeSpan BioSciences, Inc, Assay Genie, Arigo Biolaboratories Corp., RayBiotech, Inc., Biorbyt, Creative Biolabs, GeneTex, OriGene Technologies, Inc., ​​Abcam, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Coagulation Factor II Antibody market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Monoclonal Antibody
    Polyclonal Antibody
    Market segment by Application
    Flow Cytometry
    ELISA
    Western Blot
    Immunoprecipitation
    Immunofluorescence
    Other
    Major players covered
    MyBiosource, Inc.
    LifeSpan BioSciences, Inc
    Assay Genie
    Arigo Biolaboratories Corp.
    RayBiotech, Inc.
    Biorbyt
    Creative Biolabs
    GeneTex
    OriGene Technologies, Inc.
    ​​Abcam
    Cell Signaling Technology, Inc.
    Abbexa
    Bio-Techne
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Coagulation Factor II Antibody product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Coagulation Factor II Antibody, with price, sales quantity, revenue, and global market share of Coagulation Factor II Antibody from 2021 to 2026.
    Chapter 3, the Coagulation Factor II Antibody competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Coagulation Factor II Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Coagulation Factor II Antibody market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Coagulation Factor II Antibody.
    Chapter 14 and 15, to describe Coagulation Factor II Antibody sales channel, distributors, customers, research findings and conclusion.

    Buy now